Mitochondrial augmentation: a promising disease-modifying strategy for mitochondrial DNA disorders Oct. 21, 2021
PDE9 inhibition shows preclinical promise for the treatment of obesity and cardiometabolic syndrome Oct. 19, 2021
RSS